IP Library Granted Patent US 7,867,194
Granted Patent B2
US 7,867,194 · App. 11/503,450 · Granted Jan 11, 2011

Drug delivery apparatus

Assignee: The Charles Stark Draper Laboratory, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,867,194
App. No.
11/503,450
Granted
Jan 11, 2011
Kind
B2
Abstract

An implantable drug delivery apparatus for delivering a drug into a bodily fluid in a body cavity of a patient over a period of time includes a variable-volume vessel defining a working chamber for receiving a drug and recirculating a therapeutic fluid. The fluid can contain a bodily fluid, such as, for example, perilymph, and a drug. The device allows for the controlled delivery of the therapeutic fluid to a predetermined location in the bodily cavity of the patient, such as, for example, a cochlea of a human ear.

Claims (29)

1. A drug delivery apparatus for delivering a drug into a bodily fluid in a bodily cavity over a period of time, the apparatus comprising:

a cannula facilitating fluid flow through a single lumen thereof to and from the bodily cavity;

a variable-volume vessel defining a working chamber in fluid communication with the cannula and with a drug storage element;

an actuator for alternately:

delivering fluid from the working chamber to the bodily cavity through the lumen of the cannula and drawing fluid from the bodily cavity into the working chamber through the lumen of the cannula.

2. The apparatus of claim 1 wherein the bodily cavity is a cochlea of a human ear.

3. The apparatus of claim 1 wherein a concentration of the drug in the working chamber varies as fluid is alternately drawn in and forced out.

4. The apparatus of claim 1 , wherein drug is released from the drug storage element in response to a pressure variation in the working chamber as fluid is alternatively drawn in and forced out.

5. The apparatus of claim 1 wherein the actuator periodically increases and decreases the volume of the chamber by at least one of deflecting or slidably moving at least a portion of at least one wall of the variable-volume vessel.

6. The apparatus of claim 1 wherein the variable-volume vessel comprises a slidably movable wall.

7. The apparatus of claim 1 wherein the variable-volume vessel comprises a wall having a deflectable portion.

8. The apparatus of claim 7 wherein the wall comprises a flexible membrane.

9. The apparatus of claim 1 wherein the actuator is selected from the group consisting of: electromagnetic, pneumatic, or hydraulic devices.

10. The apparatus of claim 1 wherein the actuator causes the therapeutic fluid to flow through the working chamber at a flow rate of less than about one microliter per minute.

11. The apparatus of claim 1 , further comprising a regulating system in communication with the drug storage element and the actuator for maintaining a drug concentration in the fluid.

12. The apparatus of claim 11 wherein the regulating system comprises a sensor for periodically measuring concentration of drug in the fluid.

13. The apparatus of claim 11 wherein the regulating system comprises a sensor for periodically measuring concentration of drug in the bodily fluid and transmitting the measured value of the concentration to the regulating system.

14. The apparatus of claim 1 , further comprising a control system in electric communication with the actuator for controlling a flow pattern of the fluid through the working chamber.

15. The apparatus of claim 1 wherein the variable-volume vessel and the actuator are shaped and dimensioned to fit within a mastoid cavity of a human.

16. A method for delivering a drug into a bodily fluid in a bodily cavity of a patient over a period of time, the method comprising the steps of:

(a) drawing a first volume of the bodily fluid from the patient's bodily cavity through a lumen of a cannula directly into a variable-volume vessel defining a working chamber;

(b) mixing the drug with the bodily fluid in the working chamber to thereby obtaining a therapeutic fluid; and

(c) increasing a pressure within the working chamber to release a first volume of the therapeutic fluid into the bodily cavity through the lumen of the cannula.

17. The method of claim 16 wherein the bodily cavity is a human cochlea and the bodily fluid comprises human perilymph.

18. The method of claim 16 , further comprising controllably recirculating the therapeutic fluid between the working chamber and the bodily cavity by alternately forcing fluid from the chamber out to the bodily cavity through the lumen of the cannula and drawing fluid from the bodily cavity into the chamber through the lumen of the cannula.

19. The method of claim 18 , further comprising altering concentration of the drug in the therapeutic fluid during recirculation thereof.

20. The apparatus of claim 1 , wherein fluid is delivered to the bodily cavity through the lumen of the cannula by reducing the volume of the chamber, and fluid is drawn from the bodily cavity through the cannula by increasing the volume of the chamber.

21. The apparatus of claim 1 , wherein the drug storage element comprises a drug reservoir in direct fluid communication with the working chamber.

22. The apparatus of claim 21 , further comprising a valve for periodically releasing a quantity of drug from the drug reservoir into the working chamber.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 1, 2010
From: FIERING, JASON; MESCHER, MARK
To: THE CHARLES STARK DRAPER LABORATORY, INC.
Reel/Frame 025080/0692 →
Continuity (4)
Continuation In Part 1104654000 · Jan 28, 2005
Provisional Application 6054028300 · Jan 29, 2004
Provisional Application 6060269100 · Aug 19, 2004
Related Publication 20080009836A1 · Jan 10, 2008